,Title,SizeTEM (nm),Zeta potential,Incubation plasma concentration (v/v%),Incubation NP concentration (mg/L),Centrifugation speed (g),Centrifugation time （min）,Certrifugation temperature (℃),Dispersion medium pH,SizeDLS (nm),PDI,Incubation time (h),Incubation temperature (℃),Centrifugation repetitions,NP without modification_ADM105,NP without modification_ADM70,NP without modification_Ag,NP without modification_Au,NP without modification_Ca3(PO4)2,NP without modification_CaCO3,NP without modification_Chol-DC,NP without modification_Chol-PC,NP without modification_DC-Chol-DOPE,NP without modification_DOPC-DOPE-PEG-DSPC-DPPC,NP without modification_DOPG-DOPA,NP without modification_DOTAP,NP without modification_DOTAP-Chol,NP without modification_DOTAP-Chol-DPPC,NP without modification_DOTAP-Chol-DSPC,NP without modification_DOTAP-Chol-PC,NP without modification_DOTAP-DC-Chol,NP without modification_DOTAP-DOPC-DC-Chol-DOPE,NP without modification_DOTAP-DOPC-DC-Chol-DOPE/DOPE-PEG ,NP without modification_DOTAP-DOPE,NP without modification_DOTAP-DSPC-Chol,NP without modification_DOTAP/DNA,NP without modification_DOTAP/DOPC/DC-Chol/DOPE/DOPE-PEG2k,NP without modification_DOTAP:DOPC:DC-Chol:DOPE,NP without modification_DOTAP:DOPC:DC-Chol:DOPE-PEG,NP without modification_Fe3O4,NP without modification_HSPC-Chol,NP without modification_HSPC-Chol-DSPE,NP without modification_HSPC-Chol-DSPE-PEG20000,NP without modification_HSPC-DSPG-Chol,NP without modification_LPD,NP without modification_MWCNT,NP without modification_PS,NP without modification_PSOSO3,NP without modification_SWCNT,NP without modification_Shingosine-Chol-DSPC,NP without modification_Si,NP without modification_SiO2,NP without modification_TiO2,NP without modification_zeolite,Surface modification_AC,Surface modification_AHT,Surface modification_AUT,Surface modification_BCN,Surface modification_BPEI,Surface modification_CA,Surface modification_CALNN,Surface modification_CFGAILS,Surface modification_CIT,Surface modification_COOH,Surface modification_CTAB,Surface modification_CVVIT,Surface modification_DDT,Surface modification_DTNB,Surface modification_EMT,Surface modification_F127,Surface modification_FAU,Surface modification_HDA,Surface modification_LA,Surface modification_MAA,Surface modification_MBA,Surface modification_MES,Surface modification_MHA,Surface modification_MHDA,Surface modification_MPA,Surface modification_MSA,Surface modification_MUA,Surface modification_MUEG4,Surface modification_MUTA,Surface modification_NH2,Surface modification_NT,Surface modification_OAOA,Surface modification_ODA,Surface modification_OSO3,Surface modification_PAH-SH,Surface modification_PC,Surface modification_PEEP,Surface modification_PEG,Surface modification_PEI-SH,Surface modification_PVA,Surface modification_PVP,Surface modification_SA,Surface modification_SPP,Surface modification_SiO2,Surface modification_T20,Surface modification_TP,Surface modification_TiO2,Surface modification_amino acid,Surface modification_none,Surface modification_pDNA,Incubation protein source_FBS,Incubation protein source_HP,Incubation protein source_HS,Incubation protein source_RP,Incubation protein source_RS,NP type_carbon,NP type_liposome,NP type_metal,NP type_other,NP shape_powder,NP shape_rod,NP shape_sheet,NP shape_sphere,NP shape_star,NP shape_tube,Dispersion medium_PBS,Dispersion medium_buffer,Dispersion medium_cell culture,Dispersion medium_plasma,Dispersion medium_water,Incubation culture_DMEM,Incubation culture_buffer,Incubation culture_water,Modification type_Anionic,Modification type_Cationic,Modification type_Neutral,P07357
103,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",85.6,55.6,50.0,500.0,14000,15,25,7.4,85.6,0.126944444,1.0,37,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.017379538
441,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-9.0,90.0,60.0,15300,20,4,7.4,75.0,0.051,120.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.53
45,Do plasma proteins distinguish between liposomes of varying charge density?,105.0,60.5,50.0,500.0,15000,10,25,7.0,105.0,0.239,1.0,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.09887
439,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-9.0,90.0,60.0,15300,20,4,7.4,75.0,0.051,60.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.64
430,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,30.2,-9.0,90.0,60.0,15300,20,4,7.4,72.0,0.085,2.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.72
433,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-9.0,90.0,60.0,15300,20,4,7.4,75.0,0.051,5.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.71
429,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-9.0,90.0,60.0,15300,20,4,7.4,75.0,0.051,0.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.8
533,Time evolution of nanoparticle-protein corona in human plasma: Relevance for targeted drug delivery,130.0,55.0,50.0,500.0,14000,15,25,7.0,130.0,0.2,0.5,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.07
112,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",187.4,-2.4,50.0,500.0,14000,15,25,7.4,187.4,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.305611018
398,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,129.0,-28.0,90.0,60.0,15300,20,4,7.4,133.0,0.006,60.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.75
114,The liposome-protein corona in mice and humans and its implications for in vivo delivery,208.0,-15.7,50.0,500.0,14000,15,25,7.4,208.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.38066886
410,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,141.0,-6.0,90.0,60.0,15300,20,4,7.4,158.0,0.007,15.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.58
52,Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells,118.7,15.5,50.0,500.0,14000,15,25,7.0,118.7,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.41862899
490,Surface chemistry and serum type both determine the nanoparticle-protein corona,203.0,40.8,50.0,500.0,18000,15,25,7.4,203.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,0,0.0563705
122,Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis,15.7,-25.0,50.0,1660.0,12000,10,4,7.4,17.6,0.126944444,1.0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.061887793
37,"Differential analysis of ""protein corona"" profile adsorbed onto different nonviral gene delivery systems",100.0,47.5,50.0,500.0,15000,10,25,7.0,100.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0.046139897
32,"Differential analysis of ""protein corona"" profile adsorbed onto different nonviral gene delivery systems",200.0,45.0,50.0,500.0,15000,10,25,7.0,200.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0.111045951
409,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,141.0,-6.0,90.0,60.0,15300,20,4,7.4,158.0,0.007,5.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,1.36
518,Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles,10.0,-5.87,10.0,100.0,2700,5,4,7.4,880.7,0.396,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0.06
98,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,18.11,-25.7,66.0,0.01141,19000,20,4,7.4,301.67,0.126944444,1.0,37,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,0,0.096
350,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-15.0,90.0,60.0,15300,20,4,7.4,33.0,0.045,120.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.53
640,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,10.0,-50.0,100.0,80000.0,24000,30,25,7.0,10.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.7
46,Do plasma proteins distinguish between liposomes of varying charge density?,105.0,60.5,50.0,500.0,15000,10,25,7.0,105.0,0.239,1.0,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.11569
516,Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles,10.0,-5.87,10.0,100.0,2700,5,4,7.4,880.7,0.396,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0.05
104,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",78.8,55.7,50.0,500.0,14000,15,25,7.4,78.8,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.06278602
357,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,27.2,-18.0,90.0,60.0,15300,20,4,7.4,28.0,0.063,5.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.84
494,Surface chemistry and serum type both determine the nanoparticle-protein corona,248.8,-10.9,50.0,500.0,18000,15,25,7.4,248.8,0.126944444,1.0,37,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.07337646
376,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,141.0,-21.0,90.0,60.0,15300,20,4,7.4,141.0,0.002,30.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.65
351,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,27.2,-18.0,90.0,60.0,15300,20,4,7.4,28.0,0.063,0.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.75
515,Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo,9.95,-8.9,55.0,3555.6,20000,30,4,7.4,169.0,0.126944444,1.0,25,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.28
563,The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome,103.0,-38.7,50.0,500.0,15000,20,25,7.4,159.0,0.126944444,2.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,1,0.32
315,A proteomics-based methodology to investigate the protein corona effect for targeted drug delivery,60.0,58.4,50.0,500.0,84000,30,4,7.4,60.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0.2
132,Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles,30.0,-28.9,50.0,1660.0,1000,20,25,7.4,833.4,0.41,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,1,0,0.05
477,The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells,116.6,-19.9,10.0,1000.0,15000,20,25,7.4,220.8,0.288,24.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.36
534,Time evolution of nanoparticle-protein corona in human plasma: Relevance for targeted drug delivery,130.0,55.0,50.0,500.0,14000,15,25,7.0,130.0,0.2,1.0,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.04
394,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,129.0,-28.0,90.0,60.0,15300,20,4,7.4,133.0,0.006,2.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,1.57
437,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-9.0,90.0,60.0,15300,20,4,7.4,75.0,0.051,30.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.65
48,Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles,83.5,50.5,50.0,500.0,15000,10,25,7.4,83.5,0.293,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.042141234
332,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.4,-14.0,90.0,60.0,15300,20,4,7.4,48.0,0.004,2.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.12
323,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,30.2,-10.0,90.0,60.0,15300,20,4,7.4,31.0,0.104,0.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.8
106,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",99.6,59.2,50.0,500.0,14000,15,25,7.4,99.6,0.126944444,1.0,37,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.026590693
